Arnela Saljic

Arnela Saljic

Research assistant, Postdoc

Member of:


    Publication year:
    All
    21 - 30 out of 32Page size: 10
    Sort by: 1st author
    1. Published

      P2X7 receptors: central drivers of the neurocardiac link between atrial fibrillation and depression?

      Saljic, Arnela & Heijman, J., 2024, In: Europace. 26, 2, 3 p., euae023.

      Research output: Contribution to journal › Editorial › Research › peer-review

    2. Published

      Increased fibroblast accumulation in the equine heart following persistent atrial fibrillation

      Saljic, Arnela, Fenner, Merle Friederike, Winters, J., Flethøj, M., Eggert Eggertsen, C., Carstensen, Helena, Nissen, Sarah Dalgas, Melis Hesselkilde, E., van Hunnik, A., Schotten, U., Sørensen, U., Jespersen, Thomas, Verheule, S. & Buhl, Rikke, 2021, In: IJC Heart and Vasculature. 35, 100842.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Impact of arrhythmogenic calmodulin variants on small conductance Ca2+-activated K+ (SK3) channels

      Saljic, Arnela, Muthukumarasamy, K. M., la Cour, J. M., Boddum, K., Grunnet, Morten, Berchtold, Martin Werner & Jespersen, Thomas, 2019, In: Physiological Reports. 7, 19, 13 p., e14210.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      In vivo knockdown of SK3 channels using antisense oligonucleotides protects against atrial fibrillation in rats

      Saljic, Arnela, Soattin, Luca, Trachsel, D. S., Boddum, K. & Jespersen, Thomas, Oct 2020, In: Journal of Molecular and Cellular Cardiology. 147, p. 18-26

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Recent Advances in Antiarrhythmic Drug Therapy

      Saljic, Arnela, Heijman, J. & Dobrev, D., 2023, In: Drugs. 83, 13, p. 1147 - 1160 14 p.

      Research output: Contribution to journal › Review › Research › peer-review

    6. Published

      TGF-β1-induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?

      Saljic, Arnela, Grandi, E. & Dobrev, D., 2022, In: The Journal of Clinical Investigation. 132, 13, 4 p., e161070.

      Research output: Contribution to journal › Letter › Research › peer-review

    7. Published

      Botulinum toxin for prevention of post-operative atrial fibrillation

      Saljic, Arnela, Hansen, M. E. H. & Dobrev, D., 2023, In: Naunyn-Schmiedeberg's Archives of Pharmacology. 396, 3, p. 385-388

      Research output: Contribution to journal › Editorial › Research › peer-review

    8. Published

      The impact of an atrial septal defect on the progression of atrial tachypacing-induced atrial fibrillation in a Danish Landrace pig: A case report

      Saljic, Arnela, Hertel, Julie Norup, Leonhardt, C., Nissen, Sarah Dalgas, Dobrev, D., Jepps, Thomas Andrew Qvistgaard, Jespersen, Thomas & Sattler, Stefan M, 2022, In: IJC Heart and Vasculature. 40, 3 p., 101054.

      Research output: Contribution to journal › Letter › Research › peer-review

    9. Published

      Emerging Antiarrhythmic Drugs for Atrial Fibrillation

      Saljic, Arnela, Heijman, J. & Dobrev, D., 2022, In: International Journal of Molecular Sciences. 23, 8, p. 1-32 4096.

      Research output: Contribution to journal › Review › Research › peer-review

    10. Published

      Anti-arrhythmic investigations in large animal models of atrial fibrillation

      Saljic, Arnela, Jespersen, Thomas & Buhl, Rikke, 2022, In: British Journal of Pharmacology. 179, 5, p. 838-858

      Research output: Contribution to journal › Review › Research › peer-review

    Previous 1 2 3 4 Next

    ID: 170618029